CAPPED-BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000LB38CH1

Market Closed - Deutsche Boerse AG 08:45:10 28/06/2024 pm IST
38.27 EUR +0.13% Intraday chart for CAPPED-BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month-0.39%
1 month-0.39%
Date Price Change
28/24/28 38.27 +0.13%
27/24/27 38.22 -0.05%
26/24/26 38.24 +0.03%
25/24/25 38.23 -0.31%
24/24/24 38.35 +1.08%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 08:45 pm IST

More quotes

Static data

Product typeCertificats Bonus
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer LBBW
WKN LB38CH
ISINDE000LB38CH1
Date issued 02/01/2023
Strike 40
Maturity 17/01/2025 (201 Days)
Parity 1 : 1
Emission price 29.29
Emission volume N/A
Settlement les deux
Currency EUR

Technical Indicators

Highest since issue 38.51
Lowest since issue 29.38
Spread 0.38
Spread %0.98%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.76 EUR
Average target price
39.97 EUR
Spread / Average Target
+11.78%
Consensus